Victoria Woodcock
Clinical Research Fellow
Recent publications
-
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.
Journal article
Woodcock VK. et al, (2018), Br J Cancer, 118, 770 - 776
-
Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Conference paper
Ghazaly E. et al, (2017), ANNALS OF ONCOLOGY, 28
-
Simultaneous bilateral spontaneous hydropneumothorax: a rare presentation of bilateral malignant pleural mesothelioma.
Journal article
Fayed HE. et al, (2013), BMJ Case Rep, 2013